Cargando…
Intrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: A pooled analysis
Leptomeningeal metastasis (LM) is increasingly common in patients with non-small cell lung cancer (NSCLC) due to improved treatment, and ultimately, prolonged patient survival. The current study is a pooled analysis that evaluated intrathecal chemotherapy (ITC) as a treatment for NSCLC patients with...
Autores principales: | Wu, Ya-Lan, Zhou, Lin, Lu, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950629/ https://www.ncbi.nlm.nih.gov/pubmed/27446430 http://dx.doi.org/10.3892/ol.2016.4783 |
Ejemplares similares
-
Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study
por: Zhou, Tao, et al.
Publicado: (2023) -
A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer
por: Geng, Di, et al.
Publicado: (2022) -
Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis
por: Kang, Xun, et al.
Publicado: (2022) -
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022) -
The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)